Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

ENGlobal Corp. (ENG) Records Sixth Consecutive Profitable Quarter

ENGlobal, a leading provider of engineering and automation services, today reported its financial results for the second quarter ended June 27, 2015. Second quarter 2015 revenues totaled $21.1 million, a $6.1 million decrease from $27.2 million reported for the prior year period. Net income totaled $1 million, or $0.03 per diluted share, for the quarter […]

Cumberland Pharmaceuticals, Inc. (CPIX) Building Shareholder Value with Five Commercial Products and Strong Development Pipeline

Cumberland Pharmaceuticals is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The company’s product portfolio currently features five marketed treatments – including Acetadote®, Caldolor®, Kristalose®, Vaprisol® and Omeclamox-Pak® – addressing its primary target markets of hospital acute care and gastroenterology. Cumberland owns the worldwide rights to all of […]

Dominovas Energy Corporation (DNRG) Key Management Featured in Exclusive QualityStocks Interview

QualityStocks today announces the availability of a new audio interview with Mr. Eric Fresh, Senior Vice President of Finance and Investments for Dominovas Energy Corporation (OTCQB: DNRG). The interview can be heard at www.QualityStocks.net/interview-dnrg.php. At the forefront of Dominovas Energy’s mission to deliver clean, efficient and reliable electricity to areas of the world that lack […]

FluoroPharma Medical, Inc. (FPMI) Developing Improved Diagnostic Tool for the World’s Deadliest Disease

FluoroPharma Medical is a biopharmaceutical company engaged in the discovery and development of proprietary positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD). Currently, the company is advancing two such product candidates in clinical trials – including CardioPET and BFPet – which […]

International Stem Cell Corp. (ISCOD) Prepares To Up-List, Tightens Share Structure Ahead of Landmark Parkinson’s Clinical Trial

With the success of its nine-month GLP safety (tumorigenicity) and biodistribution animal model study in Parkinson’s Disease (PD) showing a completely clean record, as zero tumor growth was observed across a batch of 300 rodents injected with the company’s ethically and proprietarily-derived human neural stem cells (hpNSCs), International Stem Cell Corp. has subsequently taken a […]

America Resources Exploration, Inc. (AREN) Leveraging the Benefits of Current Lower Commodity Price Environment

America Resources Exploration is an oil and gas exploration and production company focused on the acquisition of properties in areas with significant oil reserves. Currently, the company holds a collection of leaseholds in promising production areas around the country – including parts of Oklahoma, Texas and Utah. By diversifying its interests and remaining flexible, AREN […]

 

From Our Blog

Greenland Mines Ltd. (NASDAQ: GRML) Advances World-Class Palladium Deposit with Major Resource Upgrade

July 24, 2026

Palladium is one of the most strategically important metals on earth, and the supply chain that delivers it to Western manufacturers has never been more exposed. Into that gap steps Greenland Mines (NASDAQ: GRML), which just reported a 31% increase in its indicated palladium equivalent resource at its Skaergaard project in southeast Greenland, one of the largest undeveloped […]

Rotate your device 90° to view site.